Learn more about CURED’s Rare Diseases Pillar
The Center for Unmet, Rare, and Emerging Diseases (CURED) invites applications for the inaugural CURED: Cultivate Grant Program. This program funds research projects led by a UC Berkeley faculty member working in one of the CURED priority areas: cancer, autoimmune and inflammatory diseases, rare diseases, and infectious diseases and global health.
New treatments for cancer and heart disease and new tools to remove tumors are among seven innovations selected this year to receive a Bakar Fellows Spark Award, which includes funding, resources and mentorship to accelerate translation of faculty-led research to benefit society. Administered by the Bakar Fellows Program at UC Berkeley, the awardees include CURED Affiliates,…
CURED was featured in the Chancellor’s letter:- What happens if a disease is new, uncommon, or concentrated in developing countries?
CURED’s new approach to advance medicine and global health in Berkeley’s Inspire’s interview with professor of immunology and molecular medicine in the Department of Molecular and Cell Biology (MCB), Andrew Dillin
The Salk Institute welcomes two new Nonresident Fellows, UC Berkeley professor Andrew Dillin, PhD, and UC San Diego professor Christopher Glass, MD, PhD. The two scientists join a group of eminent scientific advisors who guide Salk’s leadership. “Andy and Chris are world-renowned researchers and great partners to Salk,” says Salk President Gerald Joyce, MD, PhD. “Their…
UC Berkeley is embarking on a new approach to advance medicine and global health. The Center for Unmet, Rare, and Emerging Diseases (CURED) will unite researchers across campus to find cures that other organizations are not pursuing. Pharmaceutical companies seek a return on their investments. Medical schools and research centers require nearby patients. But what happens…
This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time. By Nancy Walecki Excerpted from The Atlantic, read the full article here. For a decade after its discovery, CRISPR gene editing was stuck on the cusp of transforming medicine. Then, in 2023, scientists started using it on…
Assistant Professor, and CURED Affiliate, Ahmad Nabhan, who joined MCB’s faculty in January 2025, brings some valuable insight to his new position. Because he did his postdoc research at the renowned biotech firm, Genentech, he brings a valuable industry perspective to his new academic role. His decision to move from industry back to an academic…
Andreas Stahl is the Ruth Okey Professor in the Department of Nutritional Science & Toxicology at UC Berkeley. His research focuses on developing innovative strategies to combat obesity-related disorders, including Type 2 diabetes and metabolic liver diseases. Stahl’s lab explores lipid metabolism, mitochondrial function, and adipose tissue biology, with a particular interest in engineering solutions…
January 23, 2025 Samuel Diamond We regret to inform you that your manuscript has not been selected for publication. That’s how Andrew Dillin’s relationship with Genes & Development (G&D) begins. The scientific journal, published by Cold Spring Harbor Laboratory (CSHL) Press(link is external), fields hundreds of article submissions each year. It’s considered one of the top publications in…
